Volume 5, Issue 8, Pages (August 2019)

Slides:



Advertisements
Similar presentations
Finger pad tophi in a patient with Raynaud phenomenon
Advertisements

Brett R. Barlow, BS, Ryan V. Marshall, BS, MS, John David Wofford, MD 
Jeff Donovan, MD, PhD, FRCPC  JAAD Case Reports 
Checkpoint inhibitor–associated cutaneous small vessel vasculitis
Muneeb Ilyas, BSc, Amit Sharma, MD  JAAD Case Reports 
A case of leukocytoclastic vasculitis following influenza vaccination
Dorene Niv, DO, James A. Ramirez, MD, David P. Fivenson, MD 
Exploring the relationship between natural killer cells and cutaneous squamous cell carcinoma development  Muneeb Ilyas, BSc, Collin M. Costello, BS,
Stephanie M. Gallitano, MD, Alessandra Haskin, BA  JAAD Case Reports 
Direct immunofluorescence microscopy of skin biopsy samples preserved in honey  Raghavendra Rao, MD, DNB, Anuradha Jindal, MBBS, Balbir Bhogal, PhD, Sathish.
Bullous pemphigoid during ustekinumab therapy
Nonphoto-exposed initial cutaneous manifestation of lupus after zoster: A case of Wolf's isotopic reaction  Molly Storer, MS, Rosalynn M. Nazarian, MD,
A Wolf in Infection's Clothing: The Difficulties of Discerning Systemic Lupus Erythematosus from Its Infectious Sequelae  Eric S. Christenson, MD, Colin.
Finger pad tophi in a patient with Raynaud phenomenon
Digital metastasis of tongue squamous cell carcinoma
Justin Cheeley, MD, Brenda Morales-Pico, MD, Suzana John, MD 
Volume 1, Issue 6, Pages (November 2015)
Development of bullous pemphigoid during nivolumab therapy
Pyoderma gangrenosum in a patient with cutaneous T-cell lymphoma
Amber Kiyani, BDS, MS, Nabiya Shahroz, BDS  JAAD Case Reports 
Treatment of psoriasis vulgaris using low-dose naltrexone
Volume 4, Issue 8, Pages (September 2018)
Romidepsin-induced neutrophilic urticaria
Extrafacial lupus miliaris disseminatus
Leukocytoclastic vasculitis sparing a tattoo with halo effect
Linear IgA dermatosis after infliximab infusion for ulcerative colitis
Dema T. Alniemi, MD, Laura McGevna, MD  JAAD Case Reports 
Volume 5, Issue 1, Pages (January 2019)
Volume 3, Issue 4, Pages (July 2017)
Anjali Shroff, MD, Emma Guttman-Yassky, MD, PhD  JAAD Case Reports 
Nicole Maillet-Lebel, MD, Marie-Marthe Thibeault, MD, FRCPC 
Volume 4, Issue 5, Pages (June 2018)
Volume 5, Issue 2, Pages (February 2019)
Diffuse pruritic papules
Volume 1, Issue 5, Pages (September 2015)
Dermatitis herpetiformis presenting as pseudovasculitis
Pediatric psoriasis treated with apremilast
An atypical presentation of a rare disease
Hemorrhagic bullae of the oral mucosa
Acute Kidney Failure in the Third Trimester of Pregnancy
Spiny keratoderma exposes underlying renal cell carcinoma
Refractory Sweet's syndrome successfully treated with rituximab
Slowly progressive chest rash in an elderly woman
Pancreatitis as a rare manifestation of Behçet disease
Circinate oral and genital mucositis
Papules developing in an old tattoo
Volume 4, Issue 7, Pages (August 2018)
Nivolumab-induced systemic vasculitis
Volume 1, Issue 6, Pages (November 2015)
Olga Vornicova, MD, Gil Bar-Sela, MD  JAAD Case Reports 
Crescentic Glomerulonephritis Associated With Hypocomplementemic Urticarial Vasculitis Syndrome  Leah Balsam, MD, Mohammed Karim, MD, Frederick Miller,
Recalcitrant prurigo nodularis treated successfully with dupilumab
Resolution of pseudoainhum with acitretin therapy in a patient with palmoplantar keratoderma and congenital alopecia  Patricia M. Richey, MD, Mary S.
Dorene Niv, DO, James A. Ramirez, MD, David P. Fivenson, MD 
Painful violaceus bullae of the hands
Widespread hyperpigmented rash present for 1 year
Volume 5, Issue 6, Pages (June 2019)
Ustekinumab-induced subacute cutaneous lupus
Hemorrhagic bullous dermatosis caused by warfarin therapy
Volume 3, Issue 4, Pages (July 2017)
Lip ulceration in an immunocompromised patient
Generalized pustular psoriasis with a novel mutation of interleukin-36 receptor antagonist, responding to methotrexate  Yee-Leng Teoh, MD, MRCP, Yong-Kwang.
Morphea in a patient undergoing treatment with ustekinumab
Widespread cutaneous nontuberculous mycobacterial infection in the absence of bacteremia mimicking leukemia cutis  Michael Musharbash, BA, Andrew Para,
William Day, BS, Adelaida Gyurjyan-Bunch, MD, Abby Van Voorhees, MD 
Sa Rang Kim, BSc, Nour Kibbi, MD, Brittany G. Craiglow, MD 
Lymphocyte-variant hypereosinophilic syndrome presenting as chronic dermatitis and responding to mycophenolic acid  Carol Dou, BSc, Luke Y.C. Chen, MD,
Volume 5, Issue 8, Pages (August 2019)
Finger pad tophi in a patient with Raynaud phenomenon
Volume 5, Issue 8, Pages (August 2019)
Presentation transcript:

Volume 5, Issue 8, Pages 682-685 (August 2019) New-onset autoantibody-mediated nephritis during ustekinumab therapy for psoriasis in patients with and without prior systemic lupus erythematosus  Ayida Al Khalili, MD, FRCPC, Leah Scott, MD, FRCPC, Jan P. Dutz, MD, FRCPC  JAAD Case Reports  Volume 5, Issue 8, Pages 682-685 (August 2019) DOI: 10.1016/j.jdcr.2019.05.022 Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions

Fig 1 Presentation with small plaque/papular psoriasis on sun-exposed areas in a patient with prior SLE (A). Development of proximal nail fold infarcts (B) 10 months after ustekinumab therapy. Periodic acid–Schiff–stained glomerulus shows segmental endocapillary hypercellularity and a small cellular crescent (C). (Original magnification: ×200) JAAD Case Reports 2019 5, 682-685DOI: (10.1016/j.jdcr.2019.05.022) Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions

Fig 2 Palpable purpura in patient with prior psoriasis and psoriatic arthritis at 24 months of ustekinumab therapy (A). Biopsy-confirmed leukocytoclastic vasculitis with perivascular neutrophils, leukocytoclastic debris, and red blood cell extravasation with no vascular immunoglobulin or complement deposition but with full-house granular immune-reactant deposition (IgG, IgM, IgA, C3) at the basement membrane zone (B). (IgG direct immunofluorescence; original magnification, ×100.) JAAD Case Reports 2019 5, 682-685DOI: (10.1016/j.jdcr.2019.05.022) Copyright © 2019 American Academy of Dermatology, Inc. Terms and Conditions